Sergey Gurevich, M.D.
Sergey Gurevich, M.D. (gure0011@umn.edu) is an interventional cardiologist at the University of Minnesota Medical Center. His primary research interests include structural heart and coronary artery disease. He has published and is currently conducting a number of studies with a focus of improving outcomes in structural interventions using novel methods including three dimensional printing, computational fluid models, and multimodality imaging with novel visualization techniques such as augmented and mixed reality. He welcomes fellow involvement in all of these projects.
Below is a selection of his recent publications:
Reiff C, Zhingre Sanchez JD, Mattison LM, Iaizzo PA, Garcia S, Raveendran G, Gurevich S. 3-Dimensional printing to predict paravalvular regurgitation after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 Feb 20;. doi: 10.1002/ccd.28783. [Epub ahead of print] PubMed PMID: 32077222.
Oestreich B, Gurevich S, Adabag S, Kelly R, Helmer G, Raveendran G, Yannopoulos D, Biring T, Garcia S. Exposure to glucocorticoids prior to transcatheter aortic valve replacement is associated with reduced incidence of high-degree AV block and pacemaker. Cardiovasc Revasc Med. 2019 Apr;20(4):328-331. doi: 10.1016/j.carrev.2018.07.012. Epub 2018 Jul 18. PubMed PMID: 30037717.
Reiff C, Gurevich S, Bertog S, Sorajja P, Kelly R, Garcia S. Validation of STS/ACC TVT-TAVR Score in Veterans Undergoing Transcatheter Aortic Valve Replacement. J Invasive Cardiol. 2018 Dec;30(12):447-451. Epub 2018 Sep 15. PubMed PMID: 30218556.
Gurevich SG, Mattison L, Raveendran G, Garcia S. 3D Printing to Reduce Paravalvular Leak in TAVR. [Internet]. American College of Cardiology; 2018 August. Available from: https://www.acc.org/latest-in-cardiology/articles/2018/08/31/09/36/3d-printing-to-reduce- paravalvular-leak-in-tavr.
Garcia S, Kelly R, Mbai M, Gurevich S, Oestreich B, Yannopoulos D, Adabag S. Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience. Catheter Cardiovasc Interv. 2018 Aug 1;92(2):390-398. doi: 10.1002/ccd.27478. Epub 2018 Jan 9. PubMed PMID: 29316204; PubMed Central PMCID: PMC6037623.
Oestreich BA, Mbai M, Gurevich S, Nijjar PS, Adabag S, Bertog S, Kelly R, Garcia S. Computed tomography (CT) assessment of the membranous septal anatomy prior to transcatheter aortic valve replacement (TAVR) with the balloon-expandable SAPIEN 3 valve. Cardiovasc Revasc Med. 2018 Jul - Aug;19(5 Pt B):626-631. doi: 10.1016/j.carrev.2017.12.012. Epub 2017 Dec 27. PubMed PMID: 29352699.
Gurevich S, Oestreich B, Kelly RF, Mbai M, Bertog S, Yannopoulos D, Garcia S. Routine use of anticoagulation after transcatheter aortic valve replacement: Initial safety outcomes from a single-center experience. Cardiovasc Revasc Med. 2018 Jul - Aug;19(5 Pt B):621-625. doi: 10.1016/j.carrev.2017.12.001. Epub 2017 Dec 6. PubMed PMID: 29276174.